Unique Physical Properties and Interactions of the Domains of Methylated DNA Binding Protein 2

被引:86
作者
Ghosh, Rajarshi P. [2 ]
Nikitina, Tatiana [1 ]
Horowitz-Scherer, Rachel A. [1 ]
Gierasch, Lila M. [2 ,3 ,7 ]
Uversky, Vladimir N. [4 ,5 ]
Hite, Kristopher [6 ]
Hansen, Jeffrey C. [6 ]
Woodcock, Christopher L. [1 ,2 ]
机构
[1] Univ Massachusetts, Dept Biol, Amherst, MA 01003 USA
[2] Univ Massachusetts, Program Mol & Cellular Biol, Amherst, MA 01003 USA
[3] Univ Massachusetts, Dept Biochem & Mol Biol, Amherst, MA 01003 USA
[4] Indiana Univ, Sch Med, Dept Biochem & Mol Biol, Inst Intrinsically Disordered Prot Res,Ctr Comput, Indianapolis, IN 46202 USA
[5] Russian Acad Sci, Inst Biol Instrumentat, Pushchino 142290, Moscow Region, Russia
[6] Colorado State Univ, Dept Biochem & Mol Biol, Ft Collins, CO 80523 USA
[7] Univ Massachusetts, Dept Chem, Amherst, MA 01003 USA
基金
美国国家卫生研究院;
关键词
RETT-SYNDROME; SECONDARY STRUCTURE; TRANSCRIPTIONAL REPRESSOR; INTRINSIC DISORDER; HUMAN MECP2; MUTATIONS; ASSOCIATION; COMPLEX; CANCER; REGION;
D O I
10.1021/bi9019753
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Methylated DNA binding protein 2 (MeCP2) is a methyl CpG binding protein whose key role is the recognition of epigenetic information encoded in DNA methylation patterns. Mutation or misregulation of MeCP2 function leads to Rett syndrome as well as a variety of other autism spectrum disorders. Here, we have analyzed in detail the properties of six individually expressed human MeCP2 domains spanning the entire protein with emphasis on their interactions with each other, with DNA, and with nucleosomal arrays. Each domain contributes uniquely to the structure and function of the full-length protein. MeCP2 is similar to 60% unstructured, with nine interspersed alpha-molecular recognition features (alpha-MoRFs), which arc polypeptide segments predicted to acquire secondary structure upon forming complexes with binding partners. Large increases in secondary structure content are induced in some of the isolated MeCP2 domains and in the full-length protein by binding to DNA. Interactions between some MeCP2 domains in cis and Irons seen in our assays likely contribute to the structure and function of the intact protein. We also show that MeCP2 has two functional halves. The N-terminal portion contains the methylated DNA binding domain (MBD) and two highly disordered flanking domains that modulate M BD-mediated DNA binding. One of these flanking domains is also capable of autonomous DNA binding. In contrast, the C-terminal portion of the protein that harbors at least two independent DNA binding domains and a chromatin-specific binding domain is largely responsible for mediating nucleosomal array compaction and oligomerization. These findings led to new mechanistic and biochemical insights regarding the conformational modulations of this intrinsically disordered protein, and its context-dependent in vivo roles.
引用
收藏
页码:4395 / 4410
页数:16
相关论文
共 81 条
[1]   New biarsenical Ligands and tetracysteine motifs for protein labeling in vitro and in vivo: Synthesis and biological applications [J].
Adams, SR ;
Campbell, RE ;
Gross, LA ;
Martin, BR ;
Walkup, GK ;
Yao, Y ;
Llopis, J ;
Tsien, RY .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2002, 124 (21) :6063-6076
[2]   Intrinsic disorder and autonomous domain function in the multifunctional nuclear protein, MeCP2 [J].
Adams, Valerie H. ;
McBryant, Steven J. ;
Wade, Paul A. ;
Woodcock, Christopher L. ;
Hansen, Jeffrey C. .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2007, 282 (20) :15057-15064
[3]   MeCP2 interacts with HP1 and modulates its heterochromatin association during myogenic differentiation [J].
Agarwal, Noopur ;
Hardt, Tanja ;
Brero, Alessandro ;
Nowak, Danny ;
Rothbauer, Ulrich ;
Becker, Annette ;
Leonhardt, Heinrich ;
Cardoso, M. Cristina .
NUCLEIC ACIDS RESEARCH, 2007, 35 (16) :5402-5408
[4]   Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2 [J].
Amir, RE ;
Van den Veyver, IB ;
Wan, M ;
Tran, CQ ;
Francke, U ;
Zoghbi, HY .
NATURE GENETICS, 1999, 23 (02) :185-188
[5]   Methyl-CpG-binding proteins in cancer: blaming the DNA methylation messenger [J].
Ballestar, E ;
Esteller, M .
BIOCHEMISTRY AND CELL BIOLOGY, 2005, 83 (03) :374-384
[6]   Methyl-CpG binding proteins identify novel sites of epigenetic inactivation in human cancer [J].
Ballestar, E ;
Paz, MF ;
Valle, L ;
Wei, S ;
Fraga, MF ;
Espada, J ;
Cigudosa, JC ;
Huang, THM ;
Esteller, M .
EMBO JOURNAL, 2003, 22 (23) :6335-6345
[7]   Methods for the detection and analysis of protein-protein interactions [J].
Berggard, Tord ;
Linse, Sara ;
James, Peter .
PROTEOMICS, 2007, 7 (16) :2833-2842
[8]   The methyl-CpG- binding protein MECP2 is required for prostate cancer cell growth [J].
Bernard, D ;
Gil, J ;
Dumont, P ;
Rizzo, S ;
Monté, D ;
Quatannens, B ;
Hudson, D ;
Visakorpi, T ;
Fuks, F ;
de Launoit, Y .
ONCOGENE, 2006, 25 (09) :1358-1366
[9]   A WW domain binding region in methyl-CpG-binding protein MeCP2:: impact on Rett syndrome [J].
Buschdorf, JP ;
Strätling, WH .
JOURNAL OF MOLECULAR MEDICINE-JMM, 2004, 82 (02) :135-143
[10]   A novel protein, Xenopus p20, influences the stability of MeCP2 through direct interaction [J].
Carro, S ;
Bergo, A ;
Mengoni, M ;
Bachi, A ;
Badaracco, G ;
Kilstrup-Nielsen, C ;
Landsberger, N .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (24) :25623-25631